A Capital-Efficient Prescription for New Drugs: Raghuram "Ram ... NASDAQ ... I expect that to continue. With HCV, companies can start throwing off efficacy data almost as soon as they are in clinic or start dosing patients?data that the market can take to the bank. ... TLSR: Many acute stroke patients recover on their own ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment